Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: J Pediatr. 2020 Feb 4;219:48–53. doi: 10.1016/j.jpeds.2019.12.066

Table 3.

Mortality and additional neurodevelopmental findings at 18 to 22 months according to treatment assignment

Variable Display
No. / total No. (%)		 Control RR (95% CI) P-value
Death or the following neurodevelopmental outcomes:
GMFCS Level 1 -- mild CP 114/325(35.1) 134/309(43.4) 0.81(0.67,0.98) 0.035
GMFCS Level 2-3 -- moderate CP 96/325(29.5) 107/309(34.6) 0.85(0.68,1.07) 0.174
GMFCS Level 4-5 -- severe CP 85/325(26.2) 104/309(33.7) 0.78(0.61,0.99) 0.046
Bayley Cognitive 70 - 84 106/321(33.0) 125/306(40.8) 0.81(0.66-0.99) 0.047
Bayley Language 70 - 84 148/320(46.3) 164/306(53.6) 0.86(0.74,1.01) 0.079

GMFCS is the Gross Motor Function Classification System. CP is cerebral palsy. RR is the relative risk of the outcome in the Display group as compared with the Control Group. CI denotes confidence interval.